Log in

ROVI Laboratorios Farmaceuticos Rovi, S.A. BME · Spain

Laboratorios Farmaceuticos Rovi (ROVI) news

Laboratorios Farmaceuticos Rovi, S.A. is a public biotech or pharmaceutical company listed on BME under the ticker ROVI, recorded under Spain. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Laboratorios Farmaceuticos Rovi news

We have not published a story on Laboratorios Farmaceuticos Rovi yet. When there is news, it will appear here.

Questions about Laboratorios Farmaceuticos Rovi

What is the ticker symbol of Laboratorios Farmaceuticos Rovi?

Laboratorios Farmaceuticos Rovi, S.A. trades under the ticker ROVI on BME.

Where is Laboratorios Farmaceuticos Rovi listed?

Laboratorios Farmaceuticos Rovi, S.A. is listed on BME. Our directory also records these other listings: DUS:41L; FWB:41L; GETTEX:41L; HAM:41L; HAN:41L; LSE:0ILL; LSX:A0M0GQ; MUN:41L; SWB:41L; TRADEGATE:41L; VIE:ROVI; XETR:41L.

Which country or territory is Laboratorios Farmaceuticos Rovi listed under?

Our directory records Laboratorios Farmaceuticos Rovi, S.A. under Spain.

What does Laboratorios Farmaceuticos Rovi do?

Our directory classifies Laboratorios Farmaceuticos Rovi, S.A. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Laboratorios Farmaceuticos Rovi?

The ISIN recorded for Laboratorios Farmaceuticos Rovi, S.A. is ES0157261019.

Does aibio.space cover Laboratorios Farmaceuticos Rovi?

aibio.space lists Laboratorios Farmaceuticos Rovi, S.A. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Laboratorios Farmaceuticos Rovi?

Companies in our directory listed in the same country and business area as Laboratorios Farmaceuticos Rovi: Grifols, Labiana Health SA, LABORATORIO REIG JOFRE, Almirall SA, Faes Farma, Oryzon Genomics SA.

Investor discussion: Laboratorios Farmaceuticos Rovi

Members talk about Laboratorios Farmaceuticos Rovi (ROVI). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BME:ROVI on TradingView.

Listing details

Laboratorios Farmaceuticos Rovi, S.A. is a public biotech or pharmaceutical company listed on BME under the ticker ROVI, recorded under Spain. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Laboratorios Farmaceuticos Rovi, S.A.
Ticker
ROVI
Listing
BME
Country or territory
Spain
Business scope
Pharmaceuticals: Major
ISIN
ES0157261019
Other listed symbols
DUS:41L; FWB:41L; GETTEX:41L; HAM:41L; HAN:41L; LSE:0ILL; LSX:A0M0GQ; MUN:41L; SWB:41L; TRADEGATE:41L; VIE:ROVI; XETR:41L
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.